Biopharma startup Everest Medicines closes $300m Series C round led by Hillhouse, others

Biopharma startup Everest Medicines closes $300m Series C round led by Hillhouse, others

Photo: Pixabay

Biopharmaceutical startup Everest Medicines on Friday announced it has raised $310 million in a Series C funding round to finance the clinical development and commercialisation of its drug candidates.